Eli Lilly Aktie
742,50
EUR
+94,90
EUR
+14,65
%
842,00
USD
+2,10
USD
+0,25
%
nachbörslich
Werbung
Eli Lilly Aktie Analyse
| 20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 05.10.18 | Eli Lilly Outperform | BMO Capital Markets | |
| 25.07.18 | Eli Lilly Neutral | Goldman Sachs Group Inc. | |
| 08.06.18 | Eli Lilly Overweight | Cantor Fitzgerald | |
| 13.04.18 | Eli Lilly Market Perform | BMO Capital Markets | |
| 16.01.18 | Eli Lilly buy | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 27.04.17 | Eli Lilly Hold | Argus Research Company | |
| 21.04.17 | Eli Lilly Underperform | BMO Capital Markets | |
| 07.04.17 | Eli Lilly overweight | Barclays Capital | |
| 20.03.17 | Eli Lilly Neutral | UBS AG | |
| 07.12.15 | Eli Lilly Buy | Deutsche Bank AG | |
| 01.12.15 | Eli Lilly overweight | Barclays Capital | |
| 20.11.15 | Eli Lilly Outperform | BMO Capital Markets | |
| 22.07.15 | Eli Lilly Equal weight | Barclays Capital | |
| 18.06.15 | Eli Lilly Buy | Argus Research Company | |
| 08.01.15 | Eli Lilly Hold | Deutsche Bank AG | |
| 08.01.15 | Eli Lilly Neutral | UBS AG | |
| 02.07.14 | Eli Lilly Equal weight | Barclays Capital | |
| 03.07.13 | Eli Lilly kaufen | Citigroup Corp. | |
| 28.05.13 | Eli Lilly halten | Jefferies & Company Inc. | |
| 03.12.12 | Eli Lilly buy | Citigroup Corp. | |
| 13.11.12 | Eli Lilly outperform | Credit Suisse Group | |
| 15.10.12 | Eli Lilly underperform | Jefferies & Company Inc. | |
| 10.10.12 | Eli Lilly neutral | Goldman Sachs Group Inc. | |
| 09.10.12 | Eli Lilly neutral | UBS AG | |
| 01.10.12 | Eli Lilly neutral | UBS AG | |
| 01.10.12 | Eli Lilly kaufen | Die Actien-Börse | |
| 21.09.12 | Eli Lilly neutral | UBS AG | |
| 06.09.12 | Eli Lilly outperform | Sanford C. Bernstein and Co., Inc. | |
| 28.08.12 | Eli Lilly neutral | UBS AG | |
| 28.08.12 | Eli Lilly outperform | Credit Suisse Group | |
| 01.08.12 | Eli Lilly neutral | Credit Suisse Group | |
| 31.07.12 | Eli Lilly neutral | JP Morgan Chase & Co. | |
| 21.06.12 | Eli Lilly neutral | Credit Suisse Group | |
| 12.01.12 | Eli Lilly neutral | UBS AG | |
| 10.01.12 | Eli Lilly hold | Jefferies & Company Inc. | |
| 27.10.11 | Eli Lilly neutral | Citigroup Corp. | |
| 15.09.11 | Eli Lilly overweight | Barclays Capital | |
| 25.07.11 | Eli Lilly neutral | UBS AG | |
| 19.07.11 | Eli Lilly hold | Citigroup Corp. | |
| 12.07.11 | Eli Lilly hold | Citigroup Corp. | |
| 30.06.11 | Eli Lilly hold | Citigroup Corp. | |
| 01.06.11 | Eli Lilly hold | Citigroup Corp. | |
| 30.05.11 | Eli Lilly equal-weight | Barclays Capital | |
| 16.05.11 | Eli Lilly kaufen | Die Actien-Börse | |
| 20.04.11 | Eli Lilly equal-weight | Barclays Capital | |
| 15.04.11 | Eli Lilly equal-weight | Barclays Capital | |
| 07.03.11 | Eli Lilly equal-weight | Barclays Capital | |
Werbung
Werbung